GE HealthCare: falls after quarterly results
At $4.6 billion, the medical technology group's revenues fell by 1% on a reported basis and remained flat on an organic basis, with a contraction in volumes partly offset by price increases.
GE HealthCare reaffirms its targets for 2024 as a whole, including adjusted EPS of between $4.20 and $4.35, adjusted operating margin of between 15.6% and 15.9%, and organic revenue growth of around 4%.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction